{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T23:06:10Z","timestamp":1779923170583,"version":"3.53.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:00:00Z","timestamp":1567123200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"La Fondation ARC","award":["PGA120140200913"],"award-info":[{"award-number":["PGA120140200913"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40246-019-0235-1","type":"journal-article","created":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T20:01:44Z","timestamp":1567195304000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Novel analytical methods to interpret large sequencing data from small sample sizes"],"prefix":"10.1186","volume":"13","author":[{"given":"Florence","family":"Lichou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Orazio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Dulucq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Etienne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Longy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Hubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Groppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Monnereau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois-Xavier","family":"Mahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Turcq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,8,30]]},"reference":[{"key":"235_CR1","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/978-3-642-94744-5_2","volume-title":"Ergebnisse der Inneren Medizin und Kinderheilkunde","author":"F Vogel","year":"1959","unstructured":"Vogel F. Moderne Probleme der Humangenetik. In: Heilmeyer L, Schoen R, Rudder B, editors. Ergebnisse der Inneren Medizin und Kinderheilkunde. Berlin: Springer Berlin Heidelberg; 1959. p. 52\u2013125. Cited 2018 Jan 23. Available from: \n                    http:\/\/www.springerlink.com\/index\/10.1007\/978-3-642-94744-5_2\n                    \n                  ."},{"key":"235_CR2","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nrg.2016.12","volume":"17","author":"MR Nelson","year":"2016","unstructured":"Nelson MR, Johnson T, Warren L, Hughes AR, Chissoe SL, Xu C-F, et al. The genetics of drug efficacy: opportunities and challenges. Nat Rev Genet. 2016;17:197\u2013206.","journal-title":"Nat Rev Genet"},{"key":"235_CR3","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/nature15817","volume":"526","author":"MV Relling","year":"2015","unstructured":"Relling MV, Evans WE. Pharmacogenomics in the clinic. Nature. 2015;526:343\u201350.","journal-title":"Nature"},{"key":"235_CR4","doi-asserted-by":"crossref","unstructured":"Hong H. Next-generation sequencing and its impact on pharmacogenetics. J Pharmacogenomics Pharmacoproteomics. 2012;03 Cited 2018 Jan 23. Available from: \n                    https:\/\/www.omicsonline.org\/next-generation-sequencing-and-its-impact-on-pharmacogenetics-2153-0645.1000e119.php?aid=6088\n                    \n                  .","DOI":"10.4172\/2153-0645.1000e119"},{"key":"235_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1258\/cvd.2012.012001","volume":"1","author":"S Ross","year":"2012","unstructured":"Ross S, Anand SS, Joseph P, Par\u00e9 G. Promises and challenges of pharmacogenetics: an overview of study design, methodological and statistical issues. JRSM Cardiovasc Dis. 2012;1:1\u201313.","journal-title":"JRSM Cardiovasc Dis"},{"key":"235_CR6","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/tpj.2011.58","volume":"12","author":"SA Bacanu","year":"2012","unstructured":"Bacanu SA, Whittaker JC, Nelson MR. How informative is a negative finding in a small pharmacogenetic study? Pharmacogenomics J. 2012;12:93\u20135.","journal-title":"Pharmacogenomics J"},{"key":"235_CR7","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1056\/NEJM199904293401706","volume":"340","author":"CL Sawyers","year":"1999","unstructured":"Sawyers CL. Chronic myeloid leukemia. N Engl J Med. 1999;340:1330\u201340.","journal-title":"N Engl J Med"},{"key":"235_CR8","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3324\/haematol.2015.139337","volume":"101","author":"TI Mughal","year":"2016","unstructured":"Mughal TI, Radich JP, Deininger MW, Apperley JF, Hughes TP, Harrison CJ, et al. Chronic myeloid leukemia: reminiscences and dreams. Haematologica. 2016;101:541\u201358.","journal-title":"Haematologica"},{"key":"235_CR9","doi-asserted-by":"publisher","first-page":"7519","DOI":"10.1158\/1078-0432.CCR-09-1068","volume":"15","author":"D Milojkovic","year":"2009","unstructured":"Milojkovic D, Apperley J. Mechanisms of resistance to imatinib and second-generation tyrosine inhibitors in chronic myeloid leukemia. Clin Cancer Res. 2009;15:7519\u201327.","journal-title":"Clin Cancer Res"},{"key":"235_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/gm206","volume":"2","author":"S Dulucq","year":"2010","unstructured":"Dulucq S, Krajinovic M. The pharmacogenetics of imatinib. Genome Med. 2010;2:85.","journal-title":"Genome Med"},{"key":"235_CR11","doi-asserted-by":"publisher","first-page":"119","DOI":"10.3390\/molecules23010119","volume":"23","author":"R Maia","year":"2018","unstructured":"Maia R, Vasconcelos F, Souza P, Rumjanek V. Towards comprehension of the ABCB1\/P-glycoprotein role in chronic myeloid leukemia. Molecules. 2018;23:119.","journal-title":"Molecules"},{"issue":"5","key":"235_CR12","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2217\/pgs-2017-0193","volume":"19","author":"Ravindran Ankathil","year":"2018","unstructured":"Ankathil R, Azlan H, Dzarr AA, Baba AA. Pharmacogenetics and the treatment of chronic myeloid leukemia: how relevant clinically? An update. Pharmacogenomics. 2018 Cited 2018 Apr 3. \n                    https:\/\/doi.org\/10.2217\/pgs-2017-0193\n                    \n                  .","journal-title":"Pharmacogenomics"},{"key":"235_CR13","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/nature15393","volume":"526","author":"A Auton","year":"2015","unstructured":"Auton A, Abecasis GR, Altshuler DM, Durbin RM, Abecasis GR, Bentley DR, et al. A global reference for human genetic variation. Nature. 2015;526:68\u201374.","journal-title":"Nature"},{"key":"235_CR14","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.leukres.2011.06.011","volume":"36","author":"V Guillem","year":"2012","unstructured":"Guillem V, Amat P, Cervantes F, Alvarez-Larr\u00e1n A, Cervera J, Maffioli M, et al. Functional polymorphisms in SOCS1 and PTPN22 genes correlate with the response to imatinib treatment in newly diagnosed chronic-phase chronic myeloid leukemia. Leuk Res. 2012;36:174\u201381.","journal-title":"Leuk Res"},{"key":"235_CR15","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1111\/j.1440-1681.1997.tb02718.x","volume":"24","author":"R Meech","year":"1997","unstructured":"Meech R, Mackenzie PI. Structure and function of uridine diphosphate glucuronosyltransferases. Clin Exp Pharmacol Physiol. 1997;24:907\u201315.","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"235_CR16","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/j.1365-2125.2011.03911.x","volume":"71","author":"Y Liu","year":"2011","unstructured":"Liu Y, Ram\u00edrez J, Ratain MJ. Inhibition of paracetamol glucuronidation by tyrosine kinase inhibitors: inhibition of paracetamol glucuronidation by TKIs. Br J Clin Pharmacol. 2011;71:917\u201320.","journal-title":"Br J Clin Pharmacol"},{"key":"235_CR17","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/2050-7771-2-6","volume":"2","author":"N Takahashi","year":"2014","unstructured":"Takahashi N, Miura M, Kuroki J, Mitani K, Kitabayashi A, Sasaki O, et al. Multicenter phase II clinical trial of nilotinib for patients with imatinib-resistant or-intolerant chronic myeloid leukemia from the East Japan CML study group evaluation of molecular response and the efficacy and safety of nilotinib. Biomarker Res. 2014;2:6.","journal-title":"Biomarker Res"},{"key":"235_CR18","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1101\/gad.13.7.768","volume":"13","author":"WL de Laat","year":"1999","unstructured":"de Laat WL, Jaspers NG, Hoeijmakers JH. Molecular mechanism of nucleotide excision repair. Genes Dev. 1999;13:768\u201385.","journal-title":"Genes Dev"},{"key":"235_CR19","doi-asserted-by":"crossref","unstructured":"Kim JA, DHD K, Won YW, Park S, Kim HJ, Kim SH, Jang JH, Kim K, Kim YK, Lee JJ, Kim HJ, Moon JH, Sohn SK, Jung CW. Candidate pathway approach of single nucleotide polymorphism on imatinib transport\/metabolism pathway and DNA repair enzyme pathway associated with response and resistance to imatinib therapy in chronic myeloid leukemia. Blood. 2009;114(22):3284.","DOI":"10.1182\/blood.V114.22.3284.3284"},{"key":"235_CR20","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1002\/ajh.21726","volume":"85","author":"VM Guillem","year":"2010","unstructured":"Guillem VM, Cervantes F, Mart\u00ednez J, Alvarez-Larr\u00e1n A, Collado M, Cam\u00f3s M, et al. XPC genetic polymorphisms correlate with the response to imatinib treatment in patients with chronic phase chronic myeloid leukemia. Am J Hematol. 2010;85:482\u20136.","journal-title":"Am J Hematol"},{"key":"235_CR21","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1182\/blood-2013-05-501569","volume":"122","author":"M Baccarani","year":"2013","unstructured":"Baccarani M, Deininger MW, Rosti G, Hochhaus A, Soverini S, Apperley JF, et al. European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013. Blood. 2013;122:872\u201384.","journal-title":"Blood"},{"key":"235_CR22","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25:1754\u201360.","journal-title":"Bioinformatics"},{"key":"235_CR23","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297\u2013303.","journal-title":"Genome Res"},{"key":"235_CR24","doi-asserted-by":"publisher","first-page":"2748","DOI":"10.1093\/bioinformatics\/btv200","volume":"31","author":"H Vuong","year":"2015","unstructured":"Vuong H, Che A, Ravichandran S, Luke BT, Collins JR, Mudunuri US. AVIA v2.0: annotation, visualization and impact analysis of genomic variants and genes: fig. 1. Bioinformatics. 2015;31:2748\u201350.","journal-title":"Bioinformatics"},{"key":"235_CR25","doi-asserted-by":"publisher","DOI":"10.1201\/9780585363035","volume-title":"Correspondence analysis handbook","author":"J-P Benz\u00e9cri","year":"1992","unstructured":"Benz\u00e9cri J-P. Correspondence analysis handbook. New York: Marcel Dekker; 1992."},{"key":"235_CR26","doi-asserted-by":"crossref","unstructured":"Josse J, Husson F. missMDA: a package for handling missing values in multivariate data analysis. J Stat Softw. 2016;70 Cited 2018 Jan 23. Available from: \n                    http:\/\/www.jstatsoft.org\/v70\/i01\/\n                    \n                  .","DOI":"10.18637\/jss.v070.i01"},{"key":"235_CR27","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.febslet.2004.07.055","volume":"573","author":"R Breitling","year":"2004","unstructured":"Breitling R, Armengaud P, Amtmann A, Herzyk P. Rank products: a simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments. FEBS Lett. 2004;573:83\u201392.","journal-title":"FEBS Lett"},{"key":"235_CR28","doi-asserted-by":"publisher","first-page":"4481","DOI":"10.1016\/j.febslet.2010.10.012","volume":"584","author":"JA Koziol","year":"2010","unstructured":"Koziol JA. The rank product method with two samples. FEBS Lett. 2010;584:4481\u20134.","journal-title":"FEBS Lett"},{"key":"235_CR29","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1016\/0014-5793(69)80071-2","volume":"2","author":"CW Sheppard","year":"1969","unstructured":"Sheppard CW. Computer simulation of stochastic processes through model-sampling (Monte Carlo) techniques. FEBS Lett. 1969;2:S14\u201321.","journal-title":"FEBS Lett"},{"key":"235_CR30","doi-asserted-by":"publisher","unstructured":"Efron B. The jackknife, the bootstrap and other resampling plans. J Soc Ind Appl Math. 1982 Cited 2018 Apr 4. \n                    https:\/\/doi.org\/10.1137\/1.9781611970319\n                    \n                  .","DOI":"10.1137\/1.9781611970319"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-019-0235-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40246-019-0235-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-019-0235-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T23:15:56Z","timestamp":1598656556000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-019-0235-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,30]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["235"],"URL":"https:\/\/doi.org\/10.1186\/s40246-019-0235-1","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,30]]},"assertion":[{"value":"6 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 August 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consent was obtained from the patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"41"}}